• Evoke, EVERSANA Announce Commercial Launch of Gimoti™ americanpharmaceuticalreview
    October 30, 2020
    Evoke Pharma and EVERSANA™ have announced the commercial launch of Gimoti™ (metoclopramide) nasal spray for the relief of symptoms in adults with acute and recurrent diabetic gastroparesis.
  • Saluda Medical announces European Commercial launch of Evoke biospectrumasia
    September 17, 2019
    Australia headquartered Saluda Medical Pty Limited has announced the award of CE Mark and the European commercial launch of the Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (SCS) System for the treatment of chronic pain.
PharmaSources Customer Service